BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 6223045)

  • 1. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
    Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ovarian contribution to peripherally derived serum C19 conjugates.
    Matteri RK; Stanczyk FZ; Cassidenti DL; Paulson RJ; Lobo RA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):768-72. PubMed ID: 1387653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased 5 alpha-reductase activity in idiopathic hirsutism.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Jan; 43(1):74-8. PubMed ID: 3155511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 5-androstene-3 beta,17 beta-diol sulphate and 5 alpha-androstane-3 alpha,17 beta-diol sulphate in hirsute females with polycystic ovarian disease.
    Montalto J; Funder JW; Yong AB; Davies HE; Connelly JF
    J Steroid Biochem; 1990 Jun; 36(1-2):67-74. PubMed ID: 2362450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin modulates peripheral androgen metabolism.
    Serafini P; Lobo RA
    Fertil Steril; 1986 Jan; 45(1):41-6. PubMed ID: 2935426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbances of androgen secretion and metabolism in polycystic ovary syndrome.
    Lobo RA
    Clin Obstet Gynaecol; 1985 Sep; 12(3):633-47. PubMed ID: 2933204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is hirsutism an evolving syndrome?
    Toscano V; Adamo MV; Caiola S; Foli S; Petrangeli E; Casilli D; Sciarra F
    J Endocrinol; 1983 Jun; 97(3):379-87. PubMed ID: 6223108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of plasma 5 alpha-androstane-3 alpha, 17 beta-diol in the hirsute woman. A critical study of the biological diagnosis of hyperandrogenism].
    Heim J; Massart C
    Nouv Presse Med; 1982 Nov; 11(47):3495-9. PubMed ID: 6218480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women.
    Greep N; Hoopes M; Horton R
    J Clin Endocrinol Metab; 1986 Jan; 62(1):22-7. PubMed ID: 3940268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is 3 alpha-androstanediol a marker of peripheral hirsutism?
    Toscano V; Sciarra F; Adamo MV; Petrangeli E; Foli S; Caiola S; Conti C
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):314-20. PubMed ID: 6460409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women.
    Meikle AW; Odell WD
    Fertil Steril; 1986 Aug; 46(2):227-31. PubMed ID: 3015694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of human pituitary luteinizing hormone administration on plasma levels of dehydroepiandrosterone, androstenediol and their sulphates and testosterone in women with secondary amenorrhoea.
    Sirinathsinghji DJ; Mills IH
    J Endocrinol; 1983 Aug; 98(2):201-10. PubMed ID: 6223967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome.
    Lobo RA; Goebelsmann U
    J Clin Endocrinol Metab; 1981 Aug; 53(2):394-400. PubMed ID: 6265489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.